LGND
Ligand Pharmaceuticals Inc
Price:  
79.96 
USD
Volume:  
72,484.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

LGND Relative Valuation

40.6%
Upside

As of 2024-06-25, the Relative Valuation of Ligand Pharmaceuticals Inc (LGND) is 112.44 USD. This relative valuation is based on P/E multiples. With the latest stock price at 79.96 USD, the upside of Ligand Pharmaceuticals Inc based on Relative Valuation is 40.6%.

The range of the Relative Valuation is 59.74 - 195.59 USD.

Range Selected
Trailing P/E multiples 30.5x - 36.5x 30.5x
Forward P/E multiples 30.0x - 34.6x 30.8x
Fair Price 59.74 - 195.59 112.44
Upside -25.3% - 144.6% 40.6%
79.96 USD
Stock Price
112.44 USD
Fair Price

LGND Relative Valuation - Historical P/E Data

Date P/E
2024-06-24 14.91
2024-06-21 14.80
2024-06-20 14.88
2024-06-18 15.01
2024-06-17 15.03
2024-06-14 14.92
2024-06-13 15.16
2024-06-12 14.94
2024-06-11 14.93
2024-06-10 14.83
2024-06-07 15.17
2024-06-06 15.35
2024-06-05 15.58
2024-06-04 15.07
2024-06-03 16.39
2024-05-31 15.85
2024-05-30 15.65
2024-05-29 15.84
2024-05-28 16.03
2024-05-24 16.11
2024-05-23 15.83
2024-05-22 16.27
2024-05-21 16.22
2024-05-20 16.15
2024-05-17 16.04
2024-05-16 15.85
2024-05-15 15.99
2024-05-14 15.90
2024-05-13 15.67
2024-05-10 16.27
2024-05-09 16.05
2024-05-08 14.98
2024-05-07 13.65
2024-05-06 13.58
2024-05-03 13.78
2024-05-02 13.48
2024-05-01 13.31
2024-04-30 13.03
2024-04-29 13.13
2024-04-26 13.15
2024-04-25 13.12
2024-04-24 13.24
2024-04-23 13.03
2024-04-22 12.77
2024-04-19 13.51
2024-04-18 13.52
2024-04-17 14.70
2024-04-16 14.90
2024-04-15 14.87
2024-04-12 15.17